Long-term follow-up of implantable cardioverter defibrillator therapy for hypertrophic cardiomyopathy

American Journal of Cardiology

Volumn 93, Issue 9, 2004, Pages 1192-1194

  Jayatilleke, Irandi ^b   Doolan, Alessandra ^b   Ingles, Jodie ^b   McGuire, Mark ^b   Booth, Virginia ^b   Richmond, David R ^b   Semsarian, Christopher ^a  

^a CENTENARY INSTITUTE   (Australia)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; AUSTRALIA; CARDIOVASCULAR RISK; CLINICAL ARTICLE; CONTROLLED STUDY; DEFIBRILLATOR; DEVICE; FOLLOW UP; HIGH RISK POPULATION; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; LONG TERM CARE; POPULATION RESEARCH; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; SUDDEN DEATH; TREATMENT OUTCOME;

ADRENERGIC BETA-ANTAGONISTS; ADULT; AUSTRALIA; CARDIOMYOPATHY, HYPERTROPHIC; DEFIBRILLATORS, IMPLANTABLE; FOLLOW-UP STUDIES; HUMANS; HYPERTROPHY, LEFT VENTRICULAR; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; RISK FACTORS; SOTALOL; TIME; TREATMENT OUTCOME;

EID: 1942436120     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2004.01.057     Document Type: Article

References (10)

1. Maron B.J., Shen W.K., Link M.S., Epstein A.E., Almquist A.K., Daubert J.P., Bardy G.H., Favale S., Rea R.F., Boriani G., et al. Efficacy of implantable cardioverter defibrillators for the prevention of sudden death in patients with hypertrophic cardiomyopathy. N Engl J Med. 342:2000;365-373.
2. Maron B.J., Estes N.A. III, Maron M.S., Almquist A.K., Link M.S., Udelson J.E. Primary prevention of sudden death as a novel treatment strategy in hypertrophic cardiomyopathy. Circulation. 107:2003;2872-2875.
3. Maron B.J. Hypertrophic cardiomyopathy and sudden death new perspectives on risk stratification and prevention with the implantable cardioverter defibrillator. Eur Heart J. 21:2000;1979-1983.
4. Maron B.J., Shirani J., Poliac L.C., Mathenge R., Roberts W.C., Mueller F.O. Sudden death in young competitive athletes - clinical, demographic, and pathological profiles. JAMA. 276:1996;199-204.
5. Maron B.J., Olivotto I., Spirito P., Casey S.A., Bellone P., Gohman T.E., Graham K.J., Burton D.A., Cecchi F. Epidemiology of hypertrophic cardiomyopathy-related death revisited in a large non-referral-based patient population. Circulation. 102:2000;858-864.
6. Elliott P.M., Poloniecki J., Dickie S., Sharma S., Monserrat L., Varnava A., Mahon N.G., McKenna W.J. Sudden death in hypertrophic cardiomyopathy identification of high risk patients. J Am Coll Cardiol. 36:2000;2212-2218.
7. Spirito P., Bellone P., Harris K.M., Bernabo P., Bruzzi P., Maron B.J. Magnitude of left ventricular hypertrophy and risk of sudden death in hypertrophic cardiomyopathy. N Engl J Med. 15:2000;1778-1785.
8. Moss A.J., Hall W.J., Cannom D.S., Daubert J.P., Higgins S.L., Klein H., Levine J.H., Saksena S., Waldo A.L., Wilber D., et al. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter automatic defibrillator implantation trial investigators. N Engl J Med. 335:1996;1933-1940.
9. The Antiarrhythmics Versus Implantable Defibrillators (AVID) Investigators. A comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. N Engl J Med. 337:1997;1576-1583.
10. Moss A.J., Zareba W., Hall W.J., Klein H., Wilber D.J., Cannom D.S., Daubert J.P., Higgins S.L., Brown M.W., Andrews M.L. Multicenter automatic defibrillator implantation trial II investigators. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med. 346:2002;877-883.